We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Tandem Diabetes Care Inc | NASDAQ:TNDM | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 8.44 | 23.09% | 45.00 | 43.57 | 45.98 | 47.00 | 42.4568 | 42.92 | 6,234,216 | 01:00:00 |
From May 2019 to May 2024
By Robb M. Stewart
Abbott Laboratories has finalized a deal with Tandem Diabetes Care Inc. to work together on automated insulin delivery systems.
Abbott said the companies will develop and commercialize systems that combine its continuous glucose monitoring technology with Tandem's insulin delivery systems to provide more options for people to manage their diabetes.
The companies first announced plans to work together in late 2019. The agreement covers technical development of device integration and associated commercial support activities.
Abbott and Tandem Diabetes Care will focus their initial commercial activities in the U.S. and Canada, with additional geographies considered in the future.
Write to Robb M. Stewart at robb.stewart@wsj.com
(END) Dow Jones Newswires
June 29, 2020 09:43 ET (13:43 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year Tandem Diabetes Care Chart |
1 Month Tandem Diabetes Care Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
